Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	333.40B
Revenue (ttm)	588.31B
Net Income (ttm)	31.88B
Shares Out	11.70M
EPS (ttm)	2,627.14
PE Ratio	10.85
Forward PE	n/a
Dividend	630.00 (2.21%)
Ex-Dividend Date	Jun 27, 2025

Volume	26,927
Average Volume	37,158
Open	28,600
Previous Close	28,600
Day's Range	28,350 - 28,850
52-Week Range	21,800 - 35,000
Beta	0.27
RSI	58.64
Earnings Date	Aug 14, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.